Scholarly article on 5α-Cholest-8(14)-en-3α-ol 18684-35-0 from Chemistry and Physics of Lipids p. 258,262

DOI: 10.1016/0009-3084(77)90013-5

Source and publish data:

Chemistry and Physics of Lipids p. 258,262 (1977)

Update date:2022-07-29

Topics:

Authors:

Parish Parish

Schroepfer

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0009-3084(77)90013-5

Full text of DOI:10.1016/0009-3084(77)90013-5

Products guided by the article

Product name:5α-Cholest-8(14)-en-3α-ol

Cas No:18684-35-0

R&D Labs maybe for 18684-35-0

BrightGene Bio-Medical Technology Co., Ltd.

website:https://en.bright-gene.com/

Contact:+86-512-62551801

Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Ji'an Kexin Trade Co., Ltd.(expird)

Contact:86-0796-8187704 18507063190

Address:ji'an jiangxi
GLD peptide scientific lnc.

Contact:21-7631221 15884421033

Address:326 Science and technology,Shanghai,China
Nantong Chem-land Co., Ltd.

Contact:86 513 85512619

Address:Rm.1306, Building A, Wenfeng Mansion,168 Gongnong Road, Nantong Jiangsu China
HuiFeiChem PharmaTech Co.Ltd

Contact:0510-85393305

Address:1619 Huishan Avenue, Huishan District, Wuxi,

Relevant to this article

Potency and inactivation rates of analogues of an irreversible inhibitor of vertebrate oxidosqualene cyclase

Doi:10.1016/S0960-894X(97)00008-5
(1997)
One-pot synthesis of some 2H-pyran-2-one derivatives

Doi:10.1002/jhet.5570330626
(1996)
Doi:10.1021/ja01077a028
(1964)
Efficient and β-stereoselective synthesis of 4(5)-methyl-5(4)-(5- amino-5-deoxy-β-D-ribofuranosyl)imidazole and related compounds exhibiting antiulcer activity

Doi:10.1248/cpb.45.53
(1997)
Doi:10.1021/ja01101a038
(1953)
Probable role of clavaminic acid as the terminal intermediate in the common pathway to clavulanic acid and the antipodal clavam metabolites

Doi:10.1021/ja963107o
(1997)

Article Doi

DOI: 10.1016/0009-3084(77)90013-5